Corporate Controller Start-Up

Michael J Irving, CPA, Fellow Chartered Secretary and Administrator

** *****, **********, ** (917) 254 - 9930 ****.*.******@*****.***

CAREER SUMMARY

Accomplished Corporate Controller, VP Finance, and CFO with a robust track record in the pharmaceutical and biotech sectors, particularly in start-up environments. A dedicated focus on process excellence has consistently contributed to elevating business performance while effectively managing costs. Proficient in designing and implementing fully automated processes to enhance operational efficiency, ensuring compliance with cGMP, SOX, and GAAP standards. Adept at cultivating trust and fostering relationships across diverse stakeholders, including investors, bankers, and regulators. Recognized expertise in consistently surpassing expectations and delivering exceptional results.

CORE COMPETENCIES

Financial and Tax Reporting

Internal & External Audits

SOX Process Redesign & Testing

Control Deficiency Remediation

ASC 606/IFRS 15 - Rev Rec.

Big 4 / Public Accounting

RPA -Robotic Process Automation

Team Mentoring & Leadership

AP and AR Automations

CRISPR Financials

Stakeholder and Sponsor Engagements

Budgets, Plans and Board Reports

Board and C level Presentations

Strategic Planning

Forecasting and Scenario Analysis

Start-up & Turnaround Operations

Sales Tax Audit - MA/NY/CA/FL

SOFTWARE COMPETENCIES

SAP, S4/Hana, Fiori, SUN, Infor, NetSuite, Oracle, ADP, Bioprocure, labsteps, Yardi Voyager, Argus, Dynamics, Sage, Concur, Blackline, Visio, Salesforce, Tipalti, Expensify, Quickbooks, Bill.com, Microsoft Word, Excel, PowerPoint, BOX and others.

EDUCATION

Bachelor of Economics, with majors in Finance, IT and Law (Melbourne Australia), Corporate Finance and Law - Australian Graduate School of Management, CPA (Australia) and Chartered Secretary and Administrator (London and Australia)

PROFESSIONAL HISTORY

VARIOUS CONSULTING ENGAGEMENTS January 2015 to Present

ENTERPRICEDB Corporate Controller (February 2023 -Present) Engaged by the CFO, a subsidiary of Bain and Company.

Conducted a business partner audit of the 2021 accounts.

Actively involved in drafting the 10-K.

INCLIN – Business Process Excellence (August 2022 – February 2023) Engaged by CFO.

Conducted a Business Process Review of CRO Operations, focusing on an Oracle Fusion Life Science implementation.

DLA ACCOUNTING-- Corporate Controller (January 2022 – August 2022) Engaged by Managing Partner New England.

Served as a Consulting Corporate Controller for ARK-Invest.

Led a Workday implementation.

Managed Lease Accounting for Wheels Up Private Jets.

Provided Year-End Audit support for Lux Research.

Involved in drafting the 10-K’s.

INARI AGRICULTURE- Corporate Controller (May2021 – January 2022)- (CRISPR Agriculture - A Flagship Pioneering Company)

Led a $400 million Series C fundraising.

Served as a Consulting Corporate Controller.

Responsible for Month-End Close, Year-End Audit, and Financials.

Oversaw Corporate Tax and Restructuring activities.

Involved in the drafting of the 10-K accounts.

COVIS PHARMACEUTICALS – Director of Revenue (February 2021 to May 2021)

Oversaw $100 million monthly sales.

Managed Gross to Net and Order to Cash activities for North American Operations

SHERLOCK BIOSCIENCES, INC- Corporate Controller (June 2020 to February 2021) CRISPR & EUL COVID19 Test Kits

Managed Corporate Controls, Finance, Accounting, and Grants.

Successfully raised $5 million in Grants.

Specialized in CRISPR technology.

Implemented the Oracle Fusion ERP Finance Module.

ULTIVUE, INC – Corporate Controller (February 2020 to Jun 2020)

Managed Corporate Controls, Finance, and Accounting.

Led Year-End Audit and Year-End Tax activities.

Updated the NetSuite ERP System.

TCR2 INC. - Accounting Manager (November 2019 to February 2020)

Specialized in Clinical Trials, CRO’s, and Process Excellence.

Responsible for Controlling and Month-End Close.

Improved Procurement and AP processes.

Redesigned FP&A for CRO’s and Clinical Trials.

Involved in drafting the 10-K and associated filings.

MODERNA – Senior Manager (March 2019 to November 2019)

Demonstrated superior cost accounting skills, involving detailed filings.

Drafted the 10-K and various filings.

Documented existing S4/Hana Fiori and New Asset Accounting Business Processes.

Recommended and implemented changes to improve business processes, aiming for integration into S4/Hana Fiori.

Transformed processes from paper documents to internal controls within S4/Hana Fiori.

Aimed for 100% compliance and full automation of business and SOX controls.

ISUBSCRIBED/INTRUSTA – Corporate Controller (September 2018 to March 2019)

Managed general accounting functions.

Oversaw revenue recognition processes.

Conducted financial systems assessments, implementations, and validations.

Contributed to Hari Ravichandran’s $1 billion second-generation technology startup in the antivirus and digital protection markets.

B-FLEXION - formerly Waypoint Group Life Science- Senior Manager (May 2018 – September2018)

Managed a $10 billion General Ledger.

Oversaw Month-End Close and Process Improvements in the SUN and Infor ERP systems.

Automated business processes, resulting in a shortened month-end close.

ARCADIA HEALTHCARE SOLUTIONS – Corporate Controller (January 2018 to May 2018)

Identified and implemented process improvements in accounting, revenue recognition, sales tax, and business systems.

Contributed to a software company managing health information cloud solutions for over 35 million patients and 50,000 medical providers and hospitals.

Successfully reduced sales tax liabilities from $1.5 million to nil.

CONVERSE / NIKE – Senior Manager (January 2016 to December 2017)

Drafted the Converse section of the 10-K and various notes.

Collaborated with the Global Director of Process Excellence to identify and implement financial efficiencies in global SAP systems, automating interfaces to AP, GL, and AR.

Managed Converse's Sales and Use Tax Audits in MA, FL, CA, NY, TX, and NC, successfully reducing liability.

Led system upgrades, including POS system enhancements for chip cards.

THE DAVIS COMPANIES – Corporate Controller (January 2015 to December 2015)

Demonstrated technical hands-on accounting skills and effective team management.

Led consolidations, managed complex tax returns, reforecasts, and facilitated refinancing activities.

Oversaw sales and acquisitions within the company.

Upgraded Yardi software and implemented Yardi Fixed Assets.

Expanded Yardi Job Cost functionalities.

REIT MANAGEMENT AND RESEARCH LLC, Boston, MA May 2013 to January 2015

Accounting Manager

Managed the Fixed Asset Department overseeing 5 listed REITs, partnerships, and family businesses, comprising 1,700+ prime commercial properties with a total value exceeding $23 billion.

Successfully upgraded the Yardi ERP system.

Implemented the Argus ERP System.

SHIRE PHARMACEUTICALS, (Global Manufacturing Pharmaceutical Group) Boston, MA April 2010 to May 2013

Accounting Manager

Involved in drafting the 10K.

Managed approximately $1 billion of Fixed Assets and $800 million in construction projects.

Oversaw the approval of all capital spends, reporting, and served as the owner of multiple SOX processes.

Served as the internal and external contact point for auditors.

Managed project management, served as the impairment process owner, and handled the production and distribution of Capex Reports.

Responsible for orphan diseases drug royalties and quality control of all orphan diseases drug invoices.

Implemented a SAP Fixed Asset module and subsequent upgrades in a $30+ million SAP upgrade.

Implemented a SAP GuiXT solution, updating thousands of transactions, reducing operator data input time by 200+ hours per week

Other

EP COMMODITIES GROUP, (Hedge Funds) Boston and Las Vegas August 2008 to April 2010

Chief Financial Officer

Held financial responsibility and control of multi-site accounting departments.

Oversaw monthly, quarterly, and annual accounting functions for the entire group, covering all special purpose funds, ventures, LPs, and other entities.

VENRO CORPORATION, (Hedge Funds), New York, NY August 2006 to August 2008

Controller

Held responsibility for all accounting functions.

Oversaw monthly, quarterly, and annual functions for an international Hedge Fund group specializing in petroleum and related products.

Successfully revised systems, reducing month-end close by 5 days.

M5 - PUBLIC ACCOUNTANTS, New York, NY January 2000 to August 2006

Boutique firm with focus on software, media, government, hedge funds and banking sectors

Senior Manager

Served as Team Leader, overseeing all accounting, budgets, filings, forecasts, and complex accounting issues.

Led the financial aspects of the $100 million Two Way Television IPO, involving royalties, rights, and gaming regulations, generating $3+ million in fees.

Appointed as acting CFO for the Firm's Investorweb client, focusing on reporting, reducing revenue recognition issues, and restructuring extensive online broking and research operations.

Realigned funds management operations and reported on $2 billion of funds under management.

KMART/COLES/MYER, New York, Australia July 1993 to January 2000

Large Top 10 retailer, multi country, multi-site, owned 25% by Kmart with $25+ billion turnover and 150,000+ employees

Served as Divisional Controller for Corporate Entities and Assistant Company Secretary

Managed all accounting aspects of Risk Management, Share Registry, Investor Relations, Shareholder Discount Plan, Catalogue Printing, Coles Myer Ansett Travel, Employee Share Plan, Coles Myer Multi Media, and the Coles Myer Foundation.

Key team member in the $2.5+ billion share buyback and $2+ billion capital reduction.

Responsible for establishing the $150 million Coles Myer Employee Share Plan for 100,000 employees, delivering significant remuneration savings.

ARTHUR ANDERSEN, Australia February 1984 to July 1993

Senior Manager

Served as a Senior Manager with extensive experience in audit, accounting, tax structuring, and project management across various sectors including retail, property, banking, finance, and not-for-profit.

Given responsibility to work on the restructure of the Myer Group, the largest client, involving the restructuring of numerous subsidiary companies.

REFERENCES Available on request

Contact this candidate